Proceedings of the Korea Environmental Mutagen Society Conference (한국환경성돌연변이발암원학회:학술대회논문집)
- 2004.11a
- /
- Pages.108-109
- /
- 2004
Point to Consider to Safety and Efficacy Assessment in Cell Therapy Products : Kfda Reviewer's Perspective
- Kim, Jong-Won (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Nam, Kyung-Tak (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Kang, Ju-Hye (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Joo, Wan-Seok (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Min, Hong-Ki (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Kang, Seog-Youn (Division of Biologics Evaluation, Korea Food and Drug Administration) ;
- Hong, Seung-Hwa (Division of Biologics Evaluation, Korea Food and Drug Administration)
- Published : 2004.11.05